MyMD Pharmaceuticals, Inc.

NASDAQ:MYMD

1.82 (USD) • At close July 23, 2024
Bedrijfsnaam MyMD Pharmaceuticals, Inc.
Symbool MYMD
Munteenheid USD
Prijs 1.81
Beurswaarde 4,290,460
Dividendpercentage 0%
52-weken bereik 1.75 - 63.9
Industrie Biotechnology
Sector Healthcare
CEO Dr. Christopher C. Chapman Jr., M.D.
Website https://www.mymd.com

An error occurred while fetching data.

Over MyMD Pharmaceuticals, Inc.

MyMD Pharmaceuticals, Inc., a clinical development stage pharmaceutical company, focuses on developing various therapeutic platforms to treat the causes of disease. The company is developing MYMD-1, a drug platform based on a clinical stage small molecule that regulates the immune system to control TNF-a, which drives chronic inflammation, and other

Vergelijkbare Aandelen

Daré Bioscience, Inc. logo

Daré Bioscience, Inc.

DARE

3.31 USD

Surrozen, Inc. logo

Surrozen, Inc.

SRZN

8.58 USD

Elevation Oncology, Inc. logo

Elevation Oncology, Inc.

ELEV

0.609 USD

Evelo Biosciences, Inc. logo

Evelo Biosciences, Inc.

EVLO

0.023 USD

Celcuity Inc. logo

Celcuity Inc.

CELC

14.98 USD

NRx Pharmaceuticals, Inc. logo

NRx Pharmaceuticals, Inc.

NRXP

1.72 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)